Topotecan in Combination With Pemetrexed in Patients With Advanced Malignancies

NCT00315861 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer
Endometrial Cancer
Cervical Cancer
Lung Cancer

Interventions

DRUG: pemetrexed
DRUG: topotecan

Sponsor

SCRI Development Innovations, LLC

Collaborators

[object Object]
[object Object]